Table 3 Health outcomes of COVID-19 survivors in the 6- and 16-month follow-up surveys
Prevalence of participants | |||||
|---|---|---|---|---|---|
in the 6 month survey (n =186) | in the 16 months survey (n = 74) | ||||
Before COVID-19 | At 6 months | Before COVID-19 | At 6 months | At 16 months | |
EQ-5D-5L | |||||
Anxiety or depression | 26 (14.0%) | 42 (22.6%) | 11 (14.9%) | 20 (27.0%) | 5/58 (8.6%) |
Pain or discomfort | 19 (10.2%) | 33 (17.7%) | 7 (9.5%) | 17 (23.0%) | 4/58 (6.9%) |
Mobility problem | 11 (5.9%) | 11 (5.9%) | 3 (4.1%) | 3 (4.1%) | 3/58 (5.2%) |
Usual activity problem | 9 (4.8%) | 11 (5.9%) | 3 (4.1%) | 4 (5.4%) | 3/58 (5.2%) |
Self-care problem | 8 (4.3%) | 8 (4.3%) | 3 (4.1%) | 2 (2.7%) | 2/58 (3.4%) |
EQ-5D-5L Value for all health* | |||||
< 1.0 | 34 (18.3%) | 56 (30.1%) | 14 (18.9%) | 21 (28.4%) | 7/58 (12.1%) |
EQ-VAS scale: 0–100 | |||||
Median (IQR) | NA | 90 (80–90) | NA | 80 (75–90) | 85 (80–90) |
CES-D (depression scale: 0–60) | |||||
≧16 (Depression) | NA | 22 (11.8%) | NA | 9 (12.1%) | 11 (14.9%) |
WG-SS | |||||
Walking | 41/184 (22.3%) | 46/184 (25.0%) | 14 (18.9%) | 17(23.0%) | 18/72 (25.0%) |
Remembering/concentrating | 39 (21.1%) | 55 (29.7%) | 18 (24.3%) | 23 (31.1%) | 32/71(45.1%) |
Seeing | 33 (17.8%) | 47 (25.4%) | 15 (20.3%) | 22 (29.7%) | 26 (36.1%) |
Hearing | 7 (3.8%) | 11 (5.9%) | 2 (2.7%) | 2 (2.7%) | 10/72 (13.9%) |
Self-care | 6 (3.2%) | 8 (4.3%) | 2 (2.7%) | 4 (5.4%) | 2/72 (2.8%) |
Language use | 2 (1.1%) | 4 (2.2%) | 1 (1.4%) | 2 (2.7%) | 1/72 (1.4%) |
Self-impressions | |||||
Not fatigue | NA | 89/186 (49.4%) | NA | 42/73 (57.5%) | 43/70 (61.4%) |
Fully recovered | NA | 153/186 (82.3%) | NA | 59 (79.7%) | 67/73 (91.8%) |
Return to original work | NA | 159/186 (85.5%) | NA | 63 (85.2%) | 56/70 (80.0%) |
Chest X-ray | |||||
Abnormal | NA | 28/184 (15.2%) | NA | 13/72 (18.1%) | 4/70 (5.7%) |
Pulmonary function test** | |||||
Obstructive pattern | NA | 11/178 (6.2%) | NA | 4/70 (5.7%) | 7/68 (10.3%) |
Restrictive pattern | NA | 66/178 (37.1%) | NA | 28/70 (40.0%) | 23/68 (33.8%) |
MRC dyspnoea scale | |||||
1 | 90/108 (83.3%) | 79/100 (79.0%) | 36/42 (85.7%) | 31/38 (81.6%) | 10/11 (90.9%) |
≧ 2 (dyspnoea) | 18 (16.7%) | 21/100 (21.0%) | 6/42 (14.3%) | 7/38 (18.4%) | 1/11 (9.1%) |